Go to deals
Healthcare | Private Equity

Igyxos S.A. has completed a Series A fundraising

Igyxos S.A. has completed a US$8.4 million fundraising as part of a Series A funding led by Bpifrance through its FABS Fund, with participation from the Go Capital Amorçage II and Loire Valley Invest Funds and by the Emergence Innovation II. This will allow the founder Marie Christine Maurel and Professor René Frydman, joined by Pierre-Henry Longeray (ex Merck Serono) as CEO, to pursue the proof of concept in human clinical practice.

Based in Nouzilly, France, biotechnology startup Igyxos is developing a new treatment for female and male infertility that works by shifting hormonal imbalances with a new method using monoclonal antibodies.

Oaklins’ team in France advised Igyxos on a "dual-track" project that allowed them to validate with the industry both scientific and therapeutic interest of its drug candidate based on the use of monoclonal antibodies to improve the treatment of female and male infertility.

“This fundraising of US$8.4 million associated with the arrival of Pierre-Henry Longeray as CEO, and the support and expertise of Professor René Frydman, who has been with us from the beginning, gives us real hope to see the treatment developed by Igyxos successfully reach the market. We thank Oaklins’ team in France for their efficient and strong support.”

Marie-Christine Maurel

CSO and Founder, Igyxos, S.A.

Talk to the deal team

 Thibaut  de Monclin

Thibaut de Monclin

Managing Partner
Paris, France
Oaklins France
 Leïla  Djebli

Leïla Djebli

Director
Paris, France
Oaklins France

Related deals

Seniovo GmbH has been acquired by HORNBACH Baumarkt AG
Private Equity | Construction & Engineering Services | TMT

Seniovo GmbH has been acquired by HORNBACH Baumarkt AG

The shareholders of Seniovo GmbH have sold the company to HORNBACH Baumarkt AG.

Learn more
Nordian Capital has raised debt to acquire Wetac
Private Equity | Energy

Nordian Capital has raised debt to acquire Wetac

Nordian Capital, a Netherlands-based private equity firm, has joined the shareholder base of Wetac Battery Company (Wetac), a leading supplier of batteries, battery systems and accessories for various applications and end markets. The financing was provided by OLB and will support Wetac’s strong growth ambitions.

Learn more
Nordian joins the shareholder base of Wetac to support further growth
Private Equity | Automotive | Energy | Logistics

Nordian joins the shareholder base of Wetac to support further growth

Nordian, a Netherlands-based private equity firm, has joined the shareholder base of Wetac, a leading supplier of batteries and battery systems for various applications and end markets.

Learn more